(Q46180712)

20 December 2017

title

Efficacy of MGI 114 (6-hydroxymethylacylfulvene, HMAF) against the mdr1/gp170 metastatic MV522 lung carcinoma xenograft (English)

1 reference

20 December 2017

1 reference

1 reference

Kelner MJ

1

1 reference

20 December 2017

McMorris TC

2

1 reference

20 December 2017

Estes L

3

1 reference

20 December 2017

Samson KM

4

1 reference

20 December 2017

Bagnell RD

5

1 reference

20 December 2017

Taetle R

6

1 reference

20 December 2017

publication date

1 May 1998

1 reference

20 December 2017

number of pages

6

1 reference

European Journal of Cancer

inferred from page(s)

published in

1 reference

20 December 2017

volume

34

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

908-913

1 reference

20 December 2017

cites work

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

The multimodality treatment of stage III A/B non-small cell lung cancer. The role of surgery, radiation, and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Preclinical evaluation of illudins as anticancer agents: basis for selective cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Structure-activity relationships of illudins: analogs with improved therapeutic index

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Characterization of illudin S sensitivity in DNA repair-deficient Chinese hamster cells. Unusually high sensitivity of ERCC2 and ERCC3 DNA helicase-deficient mutants in comparison to other chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Cell biological mechanisms of multidrug resistance in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Multidrug-resistance modulation in metastatic breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Multidrug resistance is more than MDR1 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

FUNGAL METABOLITES. THE STRUCTURES OF THE NOVEL SESQUITERPENOIDS ILLUDIN-S AND -M

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

(Hydroxymethyl)acylfulvene: an illudin derivative with superior antitumor properties

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

Bicistronic and two-gene retroviral vectors for using MDR1 as a selectable marker and a therapeutic gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900033-1

7 January 2021

10.1016/S0959-8049(98)00033-1

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017